More News

Strong arms, packed bowels during surgery and a Velcro system to stop bleeding are among the research topics to recently receive a total of $1.1 million in funding from the Maryland Technology Development Corp.

All told, 15 Maryland startups that are working with university and federal researchers received $75,000 each to help move their technologies from the lab to the marketplace.

"From devices that will make great medical contributions to technologies that will change the face of modern agriculture, Tedco's Maryland Technology Transfer and Commercialization Fund helps a wide-range of innovations become a reality," said John Wasilisin, acting president and executive director of Tedco.

The new recipients and their projects:

Amidus of Baltimore is developing technology using custom algorithms that has wide applicability, especially in the events industry.

Cognapse of Baltimore is working on a nutritional supplement, Remiva, designed to treat age-related brain diseases and disorders, such as Alzheimer's.

CYNCZ of Germantown is developing an automatic self-updating address book that can aggregate all contact data sources including e-mails, customer relationship management, mobile phones and social networking sites.

Differential Dynamics of Owings Mills is developing an all-mechanical green technology that has applications for power generation, compression, air conditioning and vehicle transmissions.

HeMemics Biotechnologies of Rockville is developing ambient-temperature shipping services to in-vitro diagnostic reagent manufacturers of cells.

Nour Immune of Annapolis is working to create "proof of concept" for the Food and Drug Administration that will demonstrate the in-vivo activity of its newly created anti-inflammatory agent in a mouse model of H1N1 flu infections.

NutriGrown of Columbia is developing soil nutrient products designed to reduce nitrogen and phosphorous leaching by up to 80 percent.

Omic Biosystems of Rockville is developing technological systems for omics-based biological sciences such as genomics, proteomics, metabolomics and system biology.

Pearl LifeScience Partners of Baltimore is bioengineering synthetic dendritic cells that can stimulate an immune response against foreign agents.

Plasmonix of Baltimore is developing metal enhanced fluorescence microplates that provide life science researchers with multiple thousand-fold increases in fluorescent signal assays with applications in biohazard detection and medical diagnostics.

Quantum Medical Metrics of Baltimore is developing a forearm strength system to accurately estimate the strength of the forearm, which is one of the most common sites of osteoporotic fractures.

Remedium Technologies of College Park is working on a propriety novel hemorrhage controlling technology called "Nano-Velcro" that is designed to be a user-friendly hemostat.

SAJE Pharma of Baltimore is developing an asthma treatment.

Seguro Surgical of Columbia is developing Lap Pak, a medical device to efficiently and securely pack bowels to expose surgical sites during major abdominal surgeries.

Viracine Therapeutics of Columbia is working on a series of genetic promoters for DNA-containing viruses infecting invertebrates, such as shrimp, that can be used to prevent plant diseases.